References
- Attar H, Bedard K, Migliavacca E, et al. (2012). Extensive natural variation of cellular hydrogen peroxide release in genetically controlled. PLoS One 7:e43566
- Campos C, Guzmán R, López-Fernández E, Casado A. (2010). Urinary uric acid and antioxidant capacity in children and adults with Down syndrome. Clin Biochem 43:228–33
- Campos C, Guzmán R, López-Fernández E, Casado A. (2011a). Evaluation of urinary biomarkers of oxidative/nitrosative stress in adolescents and adults with Down syndrome. Biochim Biophys Acta 1812:760–8
- Campos C, Guzmán R, López-Fernández E, Casado A. (2011b). Evaluation of urinary biomarkers of oxidative/nitrosative stress in children with Down syndrome. Life Sci 89:655–61
- Carratelli M, Porcaro L, Ruscica M, et al. (2001). Reactive oxygen metabolites and prooxidant status in children with Down’s syndrome. Int J Clin Pharmacol Res 21:79–84
- Guzmán R, Campos C, López-Fernández E, Casado A. (2011). Biomarkers of age effect on renal function in Down syndrome. Biomarkers 16:679–85
- Hamelet J, Seltzer V, Petit E, et al. (2008). Cystathionine beta synthase deficiency induces catalase-mediated hydrogen peroxide detoxification in mice liver. Biochim Biophys Acta 1782: 482–8
- Jovanovic SV, Clements D, MacLeod K. (1998). Biomarkers of oxidative stress are significantly elevated in Down syndrome. Free Rad Biol Med 25:1044–8
- Kedziora J, Bartosz G. (1988). Down's syndrome: a pathology involving the lack of balance of reactive oxygen species. Free Radic Biol Med 4:317–30
- Marzinzig M, Nussler AK, Stadler J, et al. (1997). Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols. Nitric Oxide 1:177–89
- Meguid NA, Dardir AA, El-Sayed EM, et al. (2010). Homocysteine and oxidative stress in Egyptian children with Down syndrome. Clin Biochem 43:963–7
- Pallardó FV, Degan P, d'Ischia M, et al. (2006). Multiple evidence for an early age pro-oxidant state in Down Syndrome patients. Biogerontology 7:211–20
- Roizen NJ, Patterson D. (2003). Down’s syndrome. Lancet 361:1281–9
- Romitelli F, Santini SA, Chierici E, et al. (2007). Comparison of nitrite/nitrate concentration in human plasma and serum samples measured by the enzymatic batch Griess assay, ion-pairing HPLC and ion-trap GC-MS: the importance of a correct removal of proteins in the Griess assay. J Chromatogr B Analyt Technol Biomed Life Sci 851:257–67
- Rowe RD, Uchida I.A. (1961). Cardiac malformation in mongolism: a prospective study of 184 mongoloid children. Am J Med 31:726–35
- Sohn YK, Ganju N, Bloch KD, et al. (1999). Neuritic sprouting with aberrant expression of the nitric oxide synthase III gene in neurodegenerative diseases. J Neurol Sci 162:133–51
- Strydom A, Dickinson MJ, Shende S, et al. (2009). Oxidative stress and cognitive ability in adults with Downsyndrom. Prog Neuropsychopharmacol Biol Psychiatry 33:76–80
- Sungur M, Ocal B, Oğuz D, et al. (2009). Plasma endothelin-1 and nitrate levels in Down’s syndrome with complete atrioventricular septal defect-associated pulmonary hypertension: a comparison with non-Down’s syndrome children. Eur J Pediatr 168:593–7
- Wennmalm A, Benthin G, Edlund A, et al. (1993). Metabolism and excretion of nitric oxide in humans: an experimental and clinical study. Circ Res 73:1121–7
- Yuen JW, Benzie IF. (2003). Hydrogen peroxide in urine as a potential biomarker of whole body oxidative stress. Free Radic Res 37:1209–13